Anti-TRIM5 alpha antibody
| Name | Anti-TRIM5 alpha antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab4389 |
| Prices | $390.00 |
| Sizes | 100 µg |
| Host | Goat |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | ELISA WB IHC-P ICC/IF ICC/IF |
| Species Reactivities | Cat, Human |
| Antigen | Synthetic peptide: ASGILVNVKEEVTC , corresponding to N terminal amino acids 2-15 of Human RNF88 |
| Description | Goat Polyclonal |
| Gene | TRIM5 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
Anti-TRIM5 alpha antibody (ab4389) at 2 µg/ml + Human placenta lysate in RIPA buffer at 35 µg
Ab4389 (1ug/ml) staining human RNF88 in human tonsil by Immunohistochemistry using paraffin embedded tissue. Microwaved antigen retrieval with citrate buffer pH 6, HRP-staining.A) positive cells next to a secondary follicleB) positive cells below tonsillar epithelium.In paraffin embedded Human Tonsil, ab4389 stains a group of cells in the interfollicular area, below the epithelium of tonsillar criptae and weak in germinal centre.
Anti-TRIM5 alpha antibody (ab4389) at 1 µg/ml + Human Brain lysate (RIPA buffer, 35µg total protein per lane).
Product References
TRIM5alpha and TRIM22 are differentially regulated according to HIV-1 infection - TRIM5alpha and TRIM22 are differentially regulated according to HIV-1 infection
Singh R, Patel V, Mureithi MW, Naranbhai V, Ramsuran D, Tulsi S, Hiramen K, Werner L, Mlisana K, Altfeld M, Luban J, Kasprowicz V, Dheda K, Abdool Karim SS, Ndung'u T. J Virol. 2014 Apr;88(8):4291-303.
Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 - Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5
Battivelli E, Migraine J, Lecossier D, Matsuoka S, Perez-Bercoff D, Saragosti S, Clavel F, Hance AJ. J Virol. 2011 Aug;85(15):7828-35.
Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from - Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from
Neagu MR, Ziegler P, Pertel T, Strambio-De-Castillia C, Grutter C, Martinetti G, Mazzucchelli L, Grutter M, Manz MG, Luban J. J Clin Invest. 2009 Oct;119(10):3035-47.
Restriction of foamy viruses by primate Trim5alpha. - Restriction of foamy viruses by primate Trim5alpha.
Yap MW, Lindemann D, Stanke N, Reh J, Westphal D, Hanenberg H, Ohkura S, Stoye JP. J Virol. 2008 Jun;82(11):5429-39.
The design of artificial retroviral restriction factors. - The design of artificial retroviral restriction factors.
Yap MW, Mortuza GB, Taylor IA, Stoye JP. Virology. 2007 Sep 1;365(2):302-14. Epub 2007 May 9.
All three variable regions of the TRIM5alpha B30.2 domain can contribute to the - All three variable regions of the TRIM5alpha B30.2 domain can contribute to the
Ohkura S, Yap MW, Sheldon T, Stoye JP. J Virol. 2006 Sep;80(17):8554-65.